Maria Palasis serves as Executive at Lyra Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Maria Palasis has executed 7 insider transactions totaling $99.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 13, 2026 involved receiving (via award) 3,997 shares valued at $0.
Maria Palasis currently holds 12,432 shares of Lyra Therapeutics, Inc. (LYRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Maria Palasis has been a net seller of LYRA stock. They have purchased $0 and sold $99.1K worth of shares.
Maria Palasis's most recent insider trade was on Jan 13, 2026, when they sold 3,997 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.36 |
| Discretionary |
| Dec 1, 2025 | BBNX | $15.0K | Sale | 500 | $29.96 | Discretionary |
| Dec 1, 2025 | BBNX | $26.6K | Sale | 906 | $29.33 | Discretionary |
| Oct 31, 2025 | BBNX | $3.3K | Sale | 119 | $27.45 | Discretionary |
| Oct 31, 2025 | BBNX | $34.6K | Sale | 1,287 | $26.86 | Discretionary |
| Jul 10, 2025 | LYRA | $13.9K | Sale | 1,565 | $8.91 | Discretionary |